[Treatment of stage I nonseminomatous testicular cancer with one cycle of adjuvant chemotherapy].
On May 1990, we began a treatment protocol for testicular stage I nonseminomatous cancer, with one chemotherapy cycle consisting of a cisplatin based combination of drugs. Until July 1996 we had admitted 18 patients, presenting five of them embryonal carcinoma and three yolk sac tumors. So far, with a median follow-up of 46.9 months, we had not relapses. 11 patients have normal long term semen analysis, with two achieving pregnancy. We believe this is acceptable alternative for treating stage I nonseminomatous cancer with scarce drugs adverse reactions. The convenience of selecting patients previous admittance, is discussed.
Corti Ortíz
D
D
Servicio y Cátedra de Urología, Universidad Austral de Chile-Hospital de Valdivia. Chile.
Fonerón Burgos
A
A
Troncoso Schifferli
L
L
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D018236:Carcinoma, Embryonal / Q000188:drug therapy / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D018240:Endodermal Sinus Tumor / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000473:pathology; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014747:Vinblastine / Q000008:administration & dosage
D001761:Bleomycin; D014747:Vinblastine; D002945:Cisplatin
Tratamiento del cáncer testicular no seminoma etapa I con un ciclo de quimioterapia adyuvante.